First real-world insights on benefit of apremilast treatment in patients with moderate to severe psoriasis after switching from fumaric acid esters from the APART Study - an interim analysis (2019) Mrowietz U, Ertner K, Sticherling M, Grosse V, Popp G, Roemmler-Zehrer J, Lampl M, et al. Conference contribution Identification of novel MRGX2-agonists triggering mast cell degranulation and potentially mediating drug-induced pruritus (2019) Kühn H, Wolf K, Boehm F, Glaudo M, Gebhardt L, Ectors P, Agelopoulos K, et al. Conference contribution Therapy Options for Patients with Advanced Basal Cell Carcinoma (2019) Kirchberger MC Conference contribution Trauma as a Trigger Factor for the First clinical Manifestation of cutaneous Leishmaniasis (2019) Hiernickel J, Bogdan C, Erfurt-Berge C Conference contribution The Art of Making Moulages - a hidden Art? (2019) Sticherling M, Groenhardt K, Saake M Conference contribution Pruritus in Psoriasis - Correlation to the Severity of the clinical appearance of the Skin? (2019) Achterberg FL, Kremer A, Sticherling M Conference contribution Multiple dermal Abscesses by Trichophyton rubrum in an immunosuppressed Patients (2019) Toussaint F, Sticherling M Conference contribution Dermatological Moulages in Germany- Comparison of Two Representative Collections (2019) Sticherling M Conference contribution Impairment of Taste and Smell in Psoriasis- another Cause of Impaired Calorie Intake? (2019) Gruenthaler V, Rueter P, Zopf Y, Sticherling M Conference contribution Dermatomyositis- a rare, but important Disease between Dermatology and Internal Medicine (2019) Sell S, Sticherling M Conference contribution